- Home
- CHRS vs BZUN Comparison
CHRS vs BZUN Comparison
Compare CHRS & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- BZUN
- Stock Information
- Founded
- CHRS 2010
- BZUN 2007
- Country
- CHRS United States
- BZUN China
- Employees
- CHRS N/A
- BZUN N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- BZUN Catalog/Specialty Distribution
- Sector
- CHRS Health Care
- BZUN Consumer Discretionary
- Exchange
- CHRS Nasdaq
- BZUN Nasdaq
- Market Cap
- CHRS 84.2M
- BZUN 131.7M
- IPO Year
- CHRS 2014
- BZUN N/A
- Fundamental
- Price
- CHRS $0.76
- BZUN $2.64
- Analyst Decision
- CHRS Buy
- BZUN Buy
- Analyst Count
- CHRS 3
- BZUN 2
- Target Price
- CHRS $4.68
- BZUN $3.20
- AVG Volume (30 Days)
- CHRS 1.3M
- BZUN 259.6K
- Earning Date
- CHRS 08-07-2025
- BZUN 05-21-2025
- Dividend Yield
- CHRS N/A
- BZUN N/A
- EPS Growth
- CHRS N/A
- BZUN N/A
- EPS
- CHRS N/A
- BZUN N/A
- Revenue
- CHRS $272,251,000.00
- BZUN $1,310,110,798.00
- Revenue This Year
- CHRS N/A
- BZUN $5.27
- Revenue Next Year
- CHRS $106.56
- BZUN $3.46
- P/E Ratio
- CHRS N/A
- BZUN N/A
- Revenue Growth
- CHRS 19.87
- BZUN 6.77
- 52 Week Low
- CHRS $0.66
- BZUN $2.11
- 52 Week High
- CHRS $2.43
- BZUN $4.38
- Technical
- Relative Strength Index (RSI)
- CHRS 46.35
- BZUN 38.22
- Support Level
- CHRS $0.72
- BZUN $2.48
- Resistance Level
- CHRS $0.77
- BZUN $2.72
- Average True Range (ATR)
- CHRS 0.04
- BZUN 0.14
- MACD
- CHRS 0.00
- BZUN -0.02
- Stochastic Oscillator
- CHRS 38.69
- BZUN 7.70
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).